Gene: ZNF710
Official Full Name: zinc finger protein 710provided by HGNC
Gene Summary: Predicted to enable DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO12035 | ZNF710 Knockout cell line (HeLa) | Human | ZNF710 | 1:3~1:6 | Negative | Online Inquiry |
KO12036 | ZNF710 Knockout cell line (HCT 116) | Human | ZNF710 | 1:2~1:4 | Negative | Online Inquiry |
KO12037 | ZNF710 Knockout cell line (HEK293) | Human | ZNF710 | 1:3~1:6 | Negative | Online Inquiry |
KO12038 | ZNF710 Knockout cell line (A549) | Human | ZNF710 | 1:3~1:4 | Negative | Online Inquiry |
ZNF710 Gene Knockout Cell Lines represent a pioneering tool in genetic research, specifically designed to enable the study of the ZNF710 gene’s role in various biological processes. These cell lines are meticulously engineered to disrupt the normal expression of the ZNF710 gene, allowing researchers to examine the effects of its absence on cellular functions and gene regulation.
The key function of ZNF710 Gene Knockout Cell Lines lies in their ability to facilitate loss-of-function studies. By utilizing CRISPR/Cas9 technology for the precise knockout, these cell lines exhibit altered phenotypes, providing a robust platform for investigating gene function, signaling pathways, and potential interactions with other genes. Moreover, the knockout cell lines can be employed in diverse experimental setups, including drug screening, model development for disease studies, and insights into cancer progression, particularly since ZNF710 has been linked to various malignancies.
From a scientific perspective, the significance of ZNF710 Gene Knockout Cell Lines cannot be overstated, as they pave the way for novel discoveries in areas such as cancer biology, regenerative medicine, and genetic disorders. Researchers and clinicians alike can harness these cell lines to explore therapeutic targets and validate drug candidates, thus enhancing translational research efforts.
Compared to traditional methods of gene knockdown, which often yield transient results, ZNF710 Gene Knockout Cell Lines offer a stable and enduring alteration in gene expression. This permanence in modification allows for more consistent and reproducible experimental outcomes, which are crucial for extensive studies and publishing robust results.
For researchers, clinicians, and pharmaceutical companies, the value of ZNF710 Gene Knockout Cell Lines lies in their ability to significantly streamline research processes while reducing overall costs associated with lengthy experimental timelines. They open up new avenues for exploration with a focus on gene role elucidation, thereby elevating the overall quality of scientific inquiry.
With a commitment to advancing biological research, our company specializes in developing and supplying high-quality genetic tools, including ZNF710 Gene Knockout Cell Lines, to foster innovation and discovery within the scientific community. Our expertise in genetic engineering ensures that we deliver products that are not only reliable but also positioned at the forefront of scientific advancement.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.